INTERNATIONAL PATENT: BAVARIAN NORDIC A/S FILES APPLICATION FOR "MODIFIED VACCINIA VIRUS ANKARA (MVA) ENCODING ANTIGEN-DISPLAYING PROTEIN NANOPARTICLES"

GENEVA, Nov. 24 -- BAVARIAN NORDIC A/S (Philip Heymans Alle 32900 Hellerup) filed a patent application (PCT/EP2025/063562) for "MODIFIED VACCINIA VIRUS ANKARA (MVA) ENCODING ANTIGEN-DISPLAYING PROTEIN NANOPARTICLES" on May 16, 2025. With publication no. WO/2025/238219, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BROD, Florian (Rothschildallee 3560389 Frankfurt am Main), HABJAN, Matthias (RainerstraBe 182178 Puchheim), HAUSMANN, Jurgen (Alte Bundesstrasse 13079194 Gundelfingen), HINTERBERGER, Maria (Deisenhofener Str. ...